Click to deselect and select. Nov 13, 2025, 12:54 AM IST AvanceTechnologies - Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September, 2025. Nov 13, 2025, 12:45 AM IST ...
Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...
Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support the production of cell and gene therapies, vaccines, and other biologic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...
The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...
Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...
We list the best Python online courses, to make it simple and easy for coders of various levels to evolve their skills with accessible tutorials. Python is one of the most popular high-level, ...
Nov 13, 2025, 12:54 AM IST AvanceTechnologies - Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September, 2025. Nov 13, 2025, 12:45 AM IST AvanceTechnologies - Board ...
ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, ...
AxoGen ((AXGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results